104 recherche sur le mot-clé 'treatment'

Treatment of anxiety in autistic adults: A systematic review / Michelle MENEZES in Research in Autism Spectrum Disorders, 99 (November)  

Public ISBD [article]  inResearch in Autism Spectrum Disorders > 99 (November) . - 102068 Titre : Treatment of anxiety in autistic adults: A systematic review Type de document : Texte imprimé et/ou numérique Auteurs : Michelle MENEZES, Auteur ; Christina HARKINS, Auteur ; Melissa F. ROBINSON, Auteur ; Jessica PAPPAGIANOPOULOS, Auteur ; Robert CROSS, Auteur ; Roma A. VASA, Auteur ; Micah O. MAZUREK, Auteur Article en page(s) : 102068 Langues : Anglais (eng) Mots-clés : Autism  ASD  Anxiety  Mental health  Treatment Index. décimale : PER Périodiques Résumé : Background Autistic adults are more likely than adults without autism spectrum disorder (ASD) to experience clinically significant anxiety. In addition, anxiety in autistic adults is associated with poorer quality of life and myriad negative outcomes (e.g., unemployment, suicidality). Therefore, this systematic review aimed to summarize and evaluate the literature on the psychotherapeutic and psychopharmacological treatment of anxiety in autistic adults to inform clinical decision-making. Method Several online databases were searched for peer-reviewed journal articles with any combination of the following terms in the abstract: (1) autism, autistic, Asperger, Asperger’s, or œpervasive developmental disorder � (2) anxiety, anxious, phobia, mutism, panic, agoraphobia, or worry and (3) treatment, intervention, trial, therapy, psychotherapy, pharmacotherapy, medication, drug, antidepressant, sedative, or anti-anxiety. Data were extracted from articles meeting the inclusion criteria, and the strength of the evidence was assessed for treatments. Results Fifteen psychosocial treatment studies, one pharmacological treatment study, and one combined psychosocial and pharmacological treatment study met the inclusion criteria. The most investigated treatment for anxiety in adults with ASD was cognitive behavioral therapy (CBT). Conclusions Few studies have investigated the treatment of anxiety in autistic adults. Additionally, findings have been inconsistent across studies regarding the potential effectiveness of particular psychosocial and pharmacological treatments. More research is certainly needed before clinically useful conclusions can be made. En ligne : https://doi.org/10.1016/j.rasd.2022.102068 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=491 [article] Treatment of anxiety in autistic adults: A systematic review [Texte imprimé et/ou numérique] / Michelle MENEZES, Auteur ; Christina HARKINS, Auteur ; Melissa F. ROBINSON, Auteur ; Jessica PAPPAGIANOPOULOS, Auteur ; Robert CROSS, Auteur ; Roma A. VASA, Auteur ; Micah O. MAZUREK, Auteur . - 102068. Langues : Anglais (eng) in Research in Autism Spectrum Disorders > 99 (November) . - 102068 Mots-clés : Autism  ASD  Anxiety  Mental health  Treatment Index. décimale : PER Périodiques Résumé : Background Autistic adults are more likely than adults without autism spectrum disorder (ASD) to experience clinically significant anxiety. In addition, anxiety in autistic adults is associated with poorer quality of life and myriad negative outcomes (e.g., unemployment, suicidality). Therefore, this systematic review aimed to summarize and evaluate the literature on the psychotherapeutic and psychopharmacological treatment of anxiety in autistic adults to inform clinical decision-making. Method Several online databases were searched for peer-reviewed journal articles with any combination of the following terms in the abstract: (1) autism, autistic, Asperger, Asperger’s, or œpervasive developmental disorder � (2) anxiety, anxious, phobia, mutism, panic, agoraphobia, or worry and (3) treatment, intervention, trial, therapy, psychotherapy, pharmacotherapy, medication, drug, antidepressant, sedative, or anti-anxiety. Data were extracted from articles meeting the inclusion criteria, and the strength of the evidence was assessed for treatments. Results Fifteen psychosocial treatment studies, one pharmacological treatment study, and one combined psychosocial and pharmacological treatment study met the inclusion criteria. The most investigated treatment for anxiety in adults with ASD was cognitive behavioral therapy (CBT). Conclusions Few studies have investigated the treatment of anxiety in autistic adults. Additionally, findings have been inconsistent across studies regarding the potential effectiveness of particular psychosocial and pharmacological treatments. More research is certainly needed before clinically useful conclusions can be made. En ligne : https://doi.org/10.1016/j.rasd.2022.102068 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=491

Treatment of Depression in Individuals with Autism Spectrum Disorder: A Systematic Review / Michelle MENEZES in Research in Autism Spectrum Disorders, 78 (October 2020)  

Public ISBD [article]  inResearch in Autism Spectrum Disorders > 78 (October 2020) . - 101639 Titre : Treatment of Depression in Individuals with Autism Spectrum Disorder: A Systematic Review Type de document : Texte imprimé et/ou numérique Auteurs : Michelle MENEZES, Auteur ; Christina HARKINS, Auteur ; Melissa F. ROBINSON, Auteur ; Micah O. MAZUREK, Auteur Article en page(s) : 101639 Langues : Anglais (eng) Mots-clés : autism spectrum disorder  depression  psychiatric comorbidity  treatment  ASD  therapy Index. décimale : PER Périodiques Résumé : Background Given the prevalence of depression in persons with autism spectrum disorder (ASD), effective treatment is crucial; however, a systemic review on the topic has not been published in over a decade. This study aimed to systematically examine the efficacy of psychosocial and pharmacological treatments for depression in youth and adults with ASD to inform clinical practice. Method PsycINFO, PubMed, and CINAHL online databases were searched for peer-reviewed journal articles containing any combination of the following terms in the abstract: (1) autism, autistic, Asperger, or “pervasive developmental disorder,” (2) depression or depressive and (3) treatment, intervention, trial, therapy, medication, drug, or antidepressant. Evidence from studies meeting the predetermined criteria of inclusion was assessed for its strength to inform clinical decision-making. Results Twenty psychosocial treatment studies and five pharmacological treatment studies met the criteria of inclusion. Psychosocial interventions studied the effectiveness of cognitive remediation therapy, behavioral therapy, cognitive-behavioral therapy (CBT), combined psychosocial intervention, mindfulness-based therapy (MBT), and social, academic, and/or vocational skills training. Pharmacological interventions studied the effectiveness of anti-epileptic drug, norepinephrine reuptake inhibitor, stimulant, atypical antipsychotic, and NMDA receptor antagonist treatment. Conclusions Although much recent research has investigated potentially effective treatments for depression in individuals with ASD, the strength of the evidence remains generally poor. However, studies indicate preliminary efficacy for MBT. A number of investigations have examined the effect of CBT on depression in persons with ASD; however, the results are inconsistent. Further research is needed to advance clinical practice for individuals with ASD and comorbid depression. En ligne : https://doi.org/10.1016/j.rasd.2020.101639 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=433 [article] Treatment of Depression in Individuals with Autism Spectrum Disorder: A Systematic Review [Texte imprimé et/ou numérique] / Michelle MENEZES, Auteur ; Christina HARKINS, Auteur ; Melissa F. ROBINSON, Auteur ; Micah O. MAZUREK, Auteur . - 101639. Langues : Anglais (eng) in Research in Autism Spectrum Disorders > 78 (October 2020) . - 101639 Mots-clés : autism spectrum disorder  depression  psychiatric comorbidity  treatment  ASD  therapy Index. décimale : PER Périodiques Résumé : Background Given the prevalence of depression in persons with autism spectrum disorder (ASD), effective treatment is crucial; however, a systemic review on the topic has not been published in over a decade. This study aimed to systematically examine the efficacy of psychosocial and pharmacological treatments for depression in youth and adults with ASD to inform clinical practice. Method PsycINFO, PubMed, and CINAHL online databases were searched for peer-reviewed journal articles containing any combination of the following terms in the abstract: (1) autism, autistic, Asperger, or “pervasive developmental disorder,” (2) depression or depressive and (3) treatment, intervention, trial, therapy, medication, drug, or antidepressant. Evidence from studies meeting the predetermined criteria of inclusion was assessed for its strength to inform clinical decision-making. Results Twenty psychosocial treatment studies and five pharmacological treatment studies met the criteria of inclusion. Psychosocial interventions studied the effectiveness of cognitive remediation therapy, behavioral therapy, cognitive-behavioral therapy (CBT), combined psychosocial intervention, mindfulness-based therapy (MBT), and social, academic, and/or vocational skills training. Pharmacological interventions studied the effectiveness of anti-epileptic drug, norepinephrine reuptake inhibitor, stimulant, atypical antipsychotic, and NMDA receptor antagonist treatment. Conclusions Although much recent research has investigated potentially effective treatments for depression in individuals with ASD, the strength of the evidence remains generally poor. However, studies indicate preliminary efficacy for MBT. A number of investigations have examined the effect of CBT on depression in persons with ASD; however, the results are inconsistent. Further research is needed to advance clinical practice for individuals with ASD and comorbid depression. En ligne : https://doi.org/10.1016/j.rasd.2020.101639 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=433

Treatment utilization by adults with autism and co-occurring anxiety or depression / Brenna B. MADDOX in Research in Autism Spectrum Disorders, 51 (July 2018)  

Public ISBD [article]  inResearch in Autism Spectrum Disorders > 51 (July 2018) . - p.32-37 Titre : Treatment utilization by adults with autism and co-occurring anxiety or depression Type de document : Texte imprimé et/ou numérique Auteurs : Brenna B. MADDOX, Auteur ; Christina D. KANG-YI, Auteur ; Edward S. BRODKIN, Auteur ; David S. MANDELL, Auteur Article en page(s) : p.32-37 Langues : Anglais (eng) Mots-clés : Autism spectrum disorder  Depression  Anxiety  Adults  Treatment  Therapy Index. décimale : PER Périodiques Résumé : Background While a growing body of research suggests that talk therapies can reduce anxiety and depression in adults with autism spectrum disorder (ASD), we know little about what community treatment for these disorders looks like for them. The present study investigated whether treatment utilization differs between adults with and without ASD who have anxiety or depression. Method Using Pennsylvania Medicaid claims data, adults aged 18–65 years diagnosed with ASD and depression or anxiety (n?=?268) were matched 1:4 to adults with depression or anxiety disorder without ASD (n?=?1072). Chi-square tests and generalized linear models were used to estimate differences in diagnoses and psychiatric treatment between groups. Results While the proportion of people prescribed benzodiazepine and antidepressants did not differ between groups, the ASD group had more days per month prescribed for all medications. Adults with ASD also were more likely to be prescribed multiple medications concurrently and to use case management. Adults without ASD were more likely to receive talk therapy for anxiety/depression. Among those receiving talk therapy, adults with ASD averaged more individual visits per month. Conclusions Findings suggest that therapists may need more session time for adults with ASD, although it is unclear if this time is dedicated to anxiety or depression treatment. The greater use of psychotropic medications among adults with ASD may suggest unresponsiveness to the talk therapy they receive or greater clinical complexity. En ligne : https://doi.org/10.1016/j.rasd.2018.03.009 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=362 [article] Treatment utilization by adults with autism and co-occurring anxiety or depression [Texte imprimé et/ou numérique] / Brenna B. MADDOX, Auteur ; Christina D. KANG-YI, Auteur ; Edward S. BRODKIN, Auteur ; David S. MANDELL, Auteur . - p.32-37. Langues : Anglais (eng) in Research in Autism Spectrum Disorders > 51 (July 2018) . - p.32-37 Mots-clés : Autism spectrum disorder  Depression  Anxiety  Adults  Treatment  Therapy Index. décimale : PER Périodiques Résumé : Background While a growing body of research suggests that talk therapies can reduce anxiety and depression in adults with autism spectrum disorder (ASD), we know little about what community treatment for these disorders looks like for them. The present study investigated whether treatment utilization differs between adults with and without ASD who have anxiety or depression. Method Using Pennsylvania Medicaid claims data, adults aged 18–65 years diagnosed with ASD and depression or anxiety (n?=?268) were matched 1:4 to adults with depression or anxiety disorder without ASD (n?=?1072). Chi-square tests and generalized linear models were used to estimate differences in diagnoses and psychiatric treatment between groups. Results While the proportion of people prescribed benzodiazepine and antidepressants did not differ between groups, the ASD group had more days per month prescribed for all medications. Adults with ASD also were more likely to be prescribed multiple medications concurrently and to use case management. Adults without ASD were more likely to receive talk therapy for anxiety/depression. Among those receiving talk therapy, adults with ASD averaged more individual visits per month. Conclusions Findings suggest that therapists may need more session time for adults with ASD, although it is unclear if this time is dedicated to anxiety or depression treatment. The greater use of psychotropic medications among adults with ASD may suggest unresponsiveness to the talk therapy they receive or greater clinical complexity. En ligne : https://doi.org/10.1016/j.rasd.2018.03.009 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=362

Collateral Effects of Behavioral Treatment for Problem Behavior on Caregiver Stress / P. F. KURTZ in Journal of Autism and Developmental Disorders, 51-8 (August 2021)  

Public ISBD [article]  inJournal of Autism and Developmental Disorders > 51-8 (August 2021) . - p.2852-2865 Titre : Collateral Effects of Behavioral Treatment for Problem Behavior on Caregiver Stress Type de document : Texte imprimé et/ou numérique Auteurs : P. F. KURTZ, Auteur ; C. W. STROHMEIER, Auteur ; J. L. BECRAFT, Auteur ; M. D. CHIN, Auteur Article en page(s) : p.2852-2865 Langues : Anglais (eng) Mots-clés : Adolescent  Adult  Behavior Therapy/methods/trends  Caregivers/psychology  Child  Child, Preschool  Female  Humans  Infant  Male  Parenting/psychology  Parents/psychology  Patient Admission/trends  Problem Behavior/psychology  Stress, Psychological/psychology/therapy  Treatment Outcome  Young Adult  Functional analysis  Parenting stress  Problem behavior  Treatment Index. décimale : PER Périodiques Résumé : When individuals with autism and intellectual and developmental disabilities exhibit severe problem behavior, assessment and treatment are often warranted. Parents of such individuals are at high risk for developing parenting stress. In this study, 194 parents completed the Parenting Stress Index-Short Form at their child's time of admission to and discharge from inpatient or outpatient treatment for severe problem behavior. Parent stress was examined in relation to rate and function of child problem behavior as determined via functional analysis. Repeated measures analyses of variance were conducted, and differential effects were observed when child participants exhibited an attention, automatic, or mands function for problem behavior. These findings highlight the importance of considering function of problem behavior in relation to parenting stress. En ligne : http://dx.doi.org/10.1007/s10803-020-04694-y Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=453 [article] Collateral Effects of Behavioral Treatment for Problem Behavior on Caregiver Stress [Texte imprimé et/ou numérique] / P. F. KURTZ, Auteur ; C. W. STROHMEIER, Auteur ; J. L. BECRAFT, Auteur ; M. D. CHIN, Auteur . - p.2852-2865. Langues : Anglais (eng) in Journal of Autism and Developmental Disorders > 51-8 (August 2021) . - p.2852-2865 Mots-clés : Adolescent  Adult  Behavior Therapy/methods/trends  Caregivers/psychology  Child  Child, Preschool  Female  Humans  Infant  Male  Parenting/psychology  Parents/psychology  Patient Admission/trends  Problem Behavior/psychology  Stress, Psychological/psychology/therapy  Treatment Outcome  Young Adult  Functional analysis  Parenting stress  Problem behavior  Treatment Index. décimale : PER Périodiques Résumé : When individuals with autism and intellectual and developmental disabilities exhibit severe problem behavior, assessment and treatment are often warranted. Parents of such individuals are at high risk for developing parenting stress. In this study, 194 parents completed the Parenting Stress Index-Short Form at their child's time of admission to and discharge from inpatient or outpatient treatment for severe problem behavior. Parent stress was examined in relation to rate and function of child problem behavior as determined via functional analysis. Repeated measures analyses of variance were conducted, and differential effects were observed when child participants exhibited an attention, automatic, or mands function for problem behavior. These findings highlight the importance of considering function of problem behavior in relation to parenting stress. En ligne : http://dx.doi.org/10.1007/s10803-020-04694-y Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=453

Age-related trends in treatment use for children with autism spectrum disorder / Sarah S. MIRE in Research in Autism Spectrum Disorders, 15-16 (July 2015)  

Public ISBD [article]  inResearch in Autism Spectrum Disorders > 15-16 (July 2015) . - p.29-41 Titre : Age-related trends in treatment use for children with autism spectrum disorder Type de document : Texte imprimé et/ou numérique Auteurs : Sarah S. MIRE, Auteur ; Natalie S. RAFF, Auteur ; Christie M. BREWTON, Auteur ; Robin P. GOIN-KOCHEL, Auteur Article en page(s) : p.29-41 Langues : Anglais (eng) Mots-clés : Autism spectrum disorder  Age-related trends  Treatment  Simons Simplex Collection Index. décimale : PER Périodiques Résumé : Numerous and increasing treatment options face parents of children with autism spectrum disorder (ASD). This study sought to elucidate age-related trends in treatment use among children with ASD from the Simons Simplex Collection (SSC; n = 2758). Our goals were to: (a) explore frequencies of use for various treatment types between preschool and adolescence, and (b) statistically compare rates of treatment-type use by children of different ages. Results indicated high reliance on school-based treatments (e.g., speech and occupational therapies), though use of these types of treatments decreased with age. Use of most treatment types peaked during the preschool years and decreased with age, except psychotropic medication, which was used more by older children. A stable proportion of the sample across ages endorsed biomedical treatments (i.e., complementary alternative medicine; CAM). Percentages of treatment-type use at three different ages (representing early childhood, middle childhood, adolescence) via Pearson chi-square analyses indicated significant associations (? < .006) between age and use of these treatment types: private and school-based speech, private and school-based occupational therapy, intensive behavioral treatment, and psychotropic medication. Results are considered within an ecological-behavioral framework to offer potential explanations for age-related differences in treatment use (e.g., family factors, special education legislation). En ligne : http://dx.doi.org/10.1016/j.rasd.2015.03.001 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=260 [article] Age-related trends in treatment use for children with autism spectrum disorder [Texte imprimé et/ou numérique] / Sarah S. MIRE, Auteur ; Natalie S. RAFF, Auteur ; Christie M. BREWTON, Auteur ; Robin P. GOIN-KOCHEL, Auteur . - p.29-41. Langues : Anglais (eng) in Research in Autism Spectrum Disorders > 15-16 (July 2015) . - p.29-41 Mots-clés : Autism spectrum disorder  Age-related trends  Treatment  Simons Simplex Collection Index. décimale : PER Périodiques Résumé : Numerous and increasing treatment options face parents of children with autism spectrum disorder (ASD). This study sought to elucidate age-related trends in treatment use among children with ASD from the Simons Simplex Collection (SSC; n = 2758). Our goals were to: (a) explore frequencies of use for various treatment types between preschool and adolescence, and (b) statistically compare rates of treatment-type use by children of different ages. Results indicated high reliance on school-based treatments (e.g., speech and occupational therapies), though use of these types of treatments decreased with age. Use of most treatment types peaked during the preschool years and decreased with age, except psychotropic medication, which was used more by older children. A stable proportion of the sample across ages endorsed biomedical treatments (i.e., complementary alternative medicine; CAM). Percentages of treatment-type use at three different ages (representing early childhood, middle childhood, adolescence) via Pearson chi-square analyses indicated significant associations (? < .006) between age and use of these treatment types: private and school-based speech, private and school-based occupational therapy, intensive behavioral treatment, and psychotropic medication. Results are considered within an ecological-behavioral framework to offer potential explanations for age-related differences in treatment use (e.g., family factors, special education legislation). En ligne : http://dx.doi.org/10.1016/j.rasd.2015.03.001 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=260

Annual Research Review: Suicide among youth - epidemiology, (potential) etiology, and treatment / Christine B. CHA in Journal of Child Psychology and Psychiatry, 59-4 (April 2018)  

Permalink

Brief Report: Relationship Between Self-Awareness of Real-World Behavior and Treatment Outcome in Autism Spectrum Disorders / E. W. M. VERHOEVEN in Journal of Autism and Developmental Disorders, 42-5 (May 2012)  

Permalink

A critical review of outcome measures used to evaluate the effectiveness of comprehensive, community based treatment for young children with ASD / Michael STOLTE in Research in Autism Spectrum Disorders, 23 (March 2016)  

Permalink

Defining behavioral components of social functioning in adults with autism spectrum disorder as targets for treatment / Ashley A. PALLATHRA in Autism Research, 11-3 (March 2018)  

Permalink

Defining Treatment Response and Symptom Remission for Anxiety Disorders in Pediatric Autism Spectrum Disorders Using the Pediatric Anxiety Rating Scale / Carly J. JOHNCO in Journal of Autism and Developmental Disorders, 45-10 (October 2015)  

Permalink